ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00717405
Brief Title: A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.

First Submitted : July 16, 2008
First Submitted that Met QC Criteria : July 16, 2008
First Posted : July 17, 2008 (Estimate)

Results First Submitted : December 1, 2015
Results First Submitted that Met QC Criteria : December 1, 2015
Results First Posted : January 6, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 5, 2016
Last Update Posted : August 2, 2016 (Estimate)